Compare CLPT & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPT | CGC |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 404.3M |
| IPO Year | 2009 | 2023 |
| Metric | CLPT | CGC |
|---|---|---|
| Price | $9.62 | $1.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.50 | N/A |
| AVG Volume (30 Days) | 940.5K | ★ 7.3M |
| Earning Date | 03-17-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.75 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,971,000.00 | $12,759,000.00 |
| Revenue This Year | $53.12 | $8.04 |
| Revenue Next Year | $32.97 | $4.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.78 | N/A |
| 52 Week Low | $8.63 | $0.77 |
| 52 Week High | $30.10 | $2.38 |
| Indicator | CLPT | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 39.38 |
| Support Level | $8.63 | $1.01 |
| Resistance Level | $11.74 | $1.24 |
| Average True Range (ATR) | 0.82 | 0.05 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 25.69 | 0.00 |
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.